South America Endoscopic Retrograde Cholangiopancreatography Market: Industry Analysis and Forecast (2024-2030)

South America Endoscopic Retrograde Cholangiopancreatography Market Definition/Overview:

South America Endoscopic Retrograde Cholangiopancreatography Market is projected to grow with a significant growth rate during the forecast period (2024-2030). The life expectancy and access to medications and healthcare of countries in the South America region have both improved during the last quarter-century. South American countries have worked hard to develop long-term healthcare and have made progress. In many countries, nearly universal coverage has been attained, but increased healthcare demand and prices pose funding and efficiency concerns. Governments have taken efforts to manage the resulting increase in healthcare costs and achieve financial sustainability, but some countries still lag behind the OECD average in terms of health spending as a proportion of GDP. The top three major attributes of the South American medical and healthcare market are ageing population, obesity epidemic and lack of efficiency. Out the three aspects ageing population and lack of efficiency is driving the Endoscopic Retrograde Cholangiopancreatography Market growth in the South American region.

To get more Insights: Request Free Sample Report

South America Endoscopic Retrograde Cholangiopancreatography Market Dynamics:

The Africa Endoscopic Retrograde Cholangiopancreatography Market in South America is projected to grow at a significant rate during the forecast period. This growth is mainly due to prevalence and acceptance for minimally invasive surgeries in the South America region. Nowadays, patients suffering from ailments like Barrett's Disease, Biliary Disease, Colitis, Crohn's Disease, Gastroesophageal Reflux Disorder (GERD), liver Disease, Pancreatitis, Inflammatory Bowel Disease, Crohn's Disease, and Peptic Ulcer Disease are opting for minimally invasive surgeries (MIS) as they offer lots of advantages over regular invasive surgeries.

The conventional invasive surgeries require large incisions and leave behind huge scars after the surgery is done. On the other hand, minimally invasive surgeries like Endoscopic Retrograde Cholangiopancreatography leave no scar behind and are also less painful. Additionally, Endoscopic Retrograde Cholangiopancreatography has other advantages like less major bleeding, fewer post-op infections, fewer complications, shorter length of stay, faster return to normal activities, less scarring, and comparable/lower cost, among other costs. As per report from SciFlo Brazil, ESD has been practiced in 22 of 26 Federation States and majority of respondents (32.2%) have 10 to 20 years of practice. ESD has been performed more frequently in private hospitals (101 individuals, 66.9%) and private ambulatory centres (41 individuals, 27.1%). ESD was performed mainly in the stomach (72%), followed by the rectum (57%) and 80% of the individuals reported less than 25 operations. Twenty-four (15.4 %) individuals reported perforation and 4 (2.5%) of them reported postoperative deaths. Approximately a quarter of responders denied hands-on training in models or visit to training centres.

Another aspect driving the Endoscopic Retrograde Cholangiopancreatography in South America is the rising percentage of ageing population that mostly requires ERCP procedures. Although South American countries are currently younger than most advanced economies, population ageing is predicted to rise in the coming years. South American women today have slightly more than two children on average, which is three times less than past several decades. Even in Guatemala and Bolivia, the region's two countries with the highest birth rates, the number of children per woman is gradually declining. Simultaneously, humans are living longer due to increased life expectancy. South Americans now enjoy a life expectancy of nearly 75 years owing to rising living standards and improved access to quality health care. Chileans and Costa Ricans have a life expectancy of more than 80 years, somewhat longer than Americans. The demographic dividend that Latin America has enjoyed since the 1970s is coming to an end due to a mix of fewer children and older adults—that is, the time during which the population aged 15 to 64 increases faster than the population less than 15 and older than 64.

South America Endoscopic Retrograde Cholangiopancreatography Market Segment Analysis:

On the basis of product type, Endoscopes and Endotherapy devices are projected to dominate the market in 2030 due to increasing rate of ageing population in the South American region. It has been observed that geriatric population experiences lot of difficulties with respect to Barrett's disease, biliary disease, colitis, Crohn's disease, gastroesophageal reflux disorder (GERD), liver disease, pancreatitis, inflammatory bowel disease, and peptic ulcer disease. All these ailments can be diagnosed with either endoscopy or Endotherapy devices and hence are driving the growth of Endoscopic Retrograde Cholangiopancreatography Market in the South American region.

On the basis of end user, the Endoscopic Retrograde Cholangiopancreatography Market in South America is dominated by hospitals and clinics as governments of constituent countries are investing heavily in order to create better healthcare infrastructure available to all the residents. The accessibility of healthcare of all is an issue in the South America region that is being addressed by the respective governments by creating a well-built and robust network of healthcare facilities.  The South American continent is home to a diverse range of countries, each with its own healthcare system. It's also the only continent where healthcare is much less expensive than anywhere in the world. All major countries on the continent, including Argentina, Brazil, Chile, Columbia, Costa Rica, and others, have universal public healthcare, making it easier for patients to avail Endoscopic Retrograde Cholangiopancreatography at minimal cost.

On the basis of application, Biliary Sphincterotomy is projected to dominate the Endoscopic Retrograde Cholangiopancreatography market as it is most commonly performed to remove bile-duct stones and is often substituted for surgical operation of the common bile duct in patients undergoing laparoscopic cholecystectomy. Biliary Sphincterotomy is also performed to facilitate the placement of stents through malignant and benign biliary strictures and for other biliary and pancreatic problems, including dysfunction of the sphincter of Oddi. Since ERCP functions as a substitute for invasive surgery it is preferred by patients. The recovery time for Pancreatic Sphincterotomy is much lesser as compared to the conventional surgery and helps in reducing hospitalization costs.  This method involves functional or structural abnormalities of the sphincter of Oddi. Sphincterotomy, or papillotomy, is a technically complex endoscopic procedure performed under visual and fluoroscopic guidance. The usual approach involves deep insertion of a cannula into the bile duct through the ampulla of Vater, followed by electrocautery to incise the sphincter of Oddi.

The objective of the report is to present a comprehensive analysis of the South America Endoscopic Retrograde Cholangiopancreatography market to the stakeholders in the industry. The report pr0ovides trends that are most dominant in the South America Endoscopic Retrograde Cholangiopancreatography market and how these trends will influence new business investments and market development throughout the forecast period. The report also aids in the comprehension of the South America Endoscopic Retrograde Cholangiopancreatography Market dynamics and competitive structure of the market by analyzing market leaders, market followers, and regional players.

The qualitative and quantitative data provided in the South America Endoscopic Retrograde Cholangiopancreatography market report is to help understand which market segments, regions are expected to grow at higher rates, factors affecting the market, and key opportunity areas, which will drive the industry and market growth through the forecast period. The report also includes the competitive landscape of key players in the industry along with their recent developments in the South America Endoscopic Retrograde Cholangiopancreatography market. The report studies factors such as company size, market share, market growth, revenue, production volume, and profits of the key players in the South America Endoscopic Retrograde Cholangiopancreatography market.

The report provides Porter's Five Force Model, which helps in designing the business strategies in the market. The report helps in identifying how many rivals are existing, who they are, and how their product quality is in the South America Endoscopic Retrograde Cholangiopancreatography market. The report also analyses if the South America Endoscopic Retrograde Cholangiopancreatography market is easy for a new player to gain a foothold in the market, do they enter or exit the market regularly if the market is dominated by a few players, etc.

The report also includes a PESTEL Analysis, which aids in the development of company strategies. Political variables help in figuring out how much a government can influence the South America Endoscopic Retrograde Cholangiopancreatography market. Economic variables aid in the analysis of economic performance drivers that have an impact on the South America Endoscopic Retrograde Cholangiopancreatography market. Understanding the impact of the surrounding environment and the influence of environmental concerns on the South America Endoscopic Retrograde Cholangiopancreatography market is aided by legal factors.

South America Endoscopic Retrograde Cholangiopancreatography Market Scope:

South America Endoscopic Retrograde Cholangiopancreatography Key Players:  

• FUJIFILM Healthcare Columbia (Columbia)
• Technomed Technologia (Venezuela)
• Pentax Medical (Brazil)
• Ethicon (Brazil)          
• Boston Scientific Middle East FZ-LLC (UAE)
• Medtronic Argentina (Argentina)
• Steris Middle East (UAE)
• Cicas SRL (Argentina)
• Arcos Biomedical (Uruguay)
• Valmi SRL (Argentina)